/Investor DB

Foresite Capital — 2025 Investments

7 investments dated 2025 · listed companies and verified rows first · show all

Riskgamingriskgaming.cominFeb 2025

Riskgaming creates immersive strategy simulation games where high-level decision-makers assume roles and navigate complex scenarios involving technology, business, and geopolitical challenges to explore alternative outcomes and inform real-world decisions.

BiotechHayward, US

Kegan Schouwenburg(Executive Officer, Director)Roger M. Perlmutter(Executive Officer, Director)in

BoardJoshua Wolfe(Director)inDror Berman(Director)Leon Chen(Director)

Board seatJames Tananbaum· per SEC Form D

Co-investorsBain Capital Life SciencesCisco InvestmentsLux CapitalDimension Capital

Latigo Biolatigobio.comSeries A · Jan 2025 · $140M

Latigo Biotherapeutics is a clinical-stage biopharmaceutical company developing non-opioid pain medicines designed to stop pain transmission without addiction risk.

BiotechHealthtechMedical DevicesThousand Oaks, US

Nima Farzan(Executive Officer, Director)Tim Lugo(Executive Officer)Sean Harper Desmond Padhi(Founder)

BoardBeth Seidenberg(Director)inJim Tananbaum(Director)inDeborah Palestrant(Director)in

Co-investors5AM VenturesAccess BiotechnologyAscenta CapitalKern Capital, LLCSanofi VenturesWestlake Village BioPartners

Mirviemirvie.cominJul 2025 · $60M

Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical.

BiotechFemTechHealthtechSouth San Francisco, US

Maneesh Jain(Founder)inStephen Quake(Founder)

BoardLisa Iverson(Director)Ursheet Parikh(Director)inMin Cui(Director)inSamir Kaul(Director)in

Co-investorsCorrelation VenturesDecheng CapitalGaingelsGeneral CatalystGV (Google Ventures)Mayfield Fund+3 more

RayTheraraythera.comSeries A · Apr 2025 · $110M

A biopharmaceutical company developing therapies for neurology, immunology, and rare diseases.

BiotechHealthtech

Co-investorsOrbiMedTTM

Thymemeetthyme.cominNov 2025 · $97MAcquired

Thyme has partnered with Altruist to create Hazel, an AI product for wealth management professionals.

AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US

Daniel Lantz(CTO)inFernando San Martin(CTO)in

Co-investorsSpringdale VenturesY CombinatorAlleyCorpConcord Health PartnersCVS Health VenturesFrist Cressey Ventures+2 more

Thyme Carethymecare.comin𝕏Sep 2025

Thyme Care develops software to enhance care coordination and outcomes for cancer patients.

Digital HealthHealthtechNashville, US

Robin Shah(Executive Officer, Director)inBobby Green(Founder)in

BoardBrian Belsky(Director)inElizabeth Canis(Director)inBrenton Fargnoli(Director)inVineeta Agarwala(Director)in

Co-investorsAlleyCorpAndreessen HorowitzCorewell Health VenturesCVS Health VenturesEcho Health VenturesFrist Cressey Ventures+6 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Indomo

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.